1. Thailand Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Genesis Fertility Center Public Company Limited

Genesis Fertility Center Public Company Limited

2.04
THB
+0.04
(+2.00%)
510.40MMarket Cap
Nov 16Next Earn
Genesis Fertility Center Public Company Limited
SET:GFC
(Stock Exchange of Thailand)

Recent

price

2.04

P/E

ratio

- -

div

yld

6.33%

ROIC.AI

2021
2022
2023
2024
2025
TTM
THB
1.1
1.25
1.98
1.69
1.6
- -
Revenue per Share
0.32
0.3
0.43
0.33
0.1
- -
Basic EPS, GAAP
0.38
-0.7
0.49
-0.47
0.24
- -
Free Cash Flow per Basic Share
0.32
0.16
0.41
0.23
0.18
0.13
Dividend per Share
0.56
0.7
2.55
2.65
2.58
2.43
Book Value per Share
0.56
0.69
2.54
2.64
2.57
2.41
Tangible Book Value per Share
220
220
179
220
220
220
Basic Weighted Avg Shares
242
276
355
372
353
- -
Sales/Revenue/Turnover
35.82
29.79
28.91
25.33
9.85
- -
Operating Margin (%)
13
15
15
20
49
- -
Depreciation Expense
70
66
77
74
22
- -
Net Income, GAAP
17.96
18.02
17.12
20.64
15.63
- -
Effective Tax Rate (%)
28.76
23.81
21.86
19.77
6.35
- -
Profit Margin (%)
70
17
284
88
101
77
Working Capital
27
165
16
25
19
16
LT Debt
124
154
566
602
590
555
Total Equity
- -
25.13
17.44
12.01
4.63
- -
Return on Invested Capital (%)
- -
25.91
17.74
12.29
3.02
- -
Return on Capital (%)
- -
47.24
21.66
12.84
3.89
- -
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
11
10
9
LT Borrowings
- -
- -
- -
LT Finance Leases
19
17
16
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
220
220
220
Market Capitalization
660
634
510

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
158
153
121
Cash, Cash Equivalents & STI
131
125
98
Accounts Receivable, Net
- -
- -
- -
Inventories
21
21
17
Total Current Liabilities
57
49
44
Payables & Accruals
37
28
24
ST Debt
11
10
9
Deferred Revenue
9
10
10

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-1.98%
Free Cash Flow
- -
- -
-149.99%
Net Income, GAAP
- -
- -
-69.52%
Sales/Revenue/Turnover
- -
- -
-5.05%
Total Cash Common Dividend
- -
- -
-21.67%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
109
82
93
88
372
2025
90
90
92
81
353
2026
- -
58
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.13
0.08
0.08
0.05
0.33
2025
0.03
0.03
0.03
0.02
0.1
2026
- -
-0.03
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.12
0.01
0.1
- -
0.23
2025
- -
0.15
0.03
- -
0.18
2026
- -
0.1
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Genesis Fertility Center Public Company Limited is a Thailand-based healthcare provider specializing in comprehensive assisted reproductive technology (ART) and infertility treatment services. The company provides a full continuum of reproductive medical care and fertility solutions for domestic and international patients, including consultation and fertility diagnostic examinations; intrauterine insemination (IUI); in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI); preimplantation genetic testing (PGT-A and PGT-M) utilizing next-generation sequencing; time-lapse embryo incubation and monitoring; cryopreservation of oocytes, sperm, and embryos; semen analysis and sperm preparation; diagnostic hysteroscopy; and personalized reproductive wellness and nutritional counseling. Founded in 2015 and headquartered in Bangkok, Thailand, Genesis Fertility Center operates specialized fertility clinics equipped with cleanroom laboratories and certified medical embryology facilities. In recent developments, the company completed its initial public offering on the Market for Alternative Investment (mai) of the Stock Exchange of Thailand, raising capital to accelerate physical and technological expansion. Genesis Fertility Center has broadened its clinical network through the establishment of new facilities, including the Rama 9-Srinakarin flagship center in Bangkok and a regional branch in Ubon Ratchathani designed to serve northeastern Thailand and cross-border patients from neighboring countries such as Laos and Cambodia. Furthermore, the company has incorporated artificial intelligence-assisted embryo evaluation tools into its laboratory operations and expanded international patient support services to capture regional demand in medical tourism.